Alexander Tenenbaum
Alexander Tenenbaum | |
|---|---|
 | |
| Born | Alexander Tenenbaum 1956 Frunze |
| Other names | Professor Alexander Tenenbaum |
Alexander Tenenbaum (Sackler Faculty of Medicine, Tel-Aviv University)[1] is an Israeli medical doctor, university professor, and researcher in the fields of cardiology and diabetes.
Education and professional work
[change | change source]Tenenbaum was born in Frunze, former Soviet Union, in 1956. This is where he graduated with a medical degree in 1978. He received a PhD in 1986. Tenenbaum’s research was in the areas of high-altitude medicine[2] heart failure[3] and pulmonary hypertension.[4]
Tenenbaum immigrated to Israel in 1989. He started his work at Sheba Medical Center. During the next twenty years he held several different jobs at this hospital. These included residency in cardiology at the Heart Institute. He was also responsible for the Echocardiography Laboratory at the Cardiac Rehabilitation Institute. In 2003 he was appointed Deputy Director of the institute. Currently he is Scientific Director at the same institute.[5]
Further scientific investigations
[change | change source]Tenenbaum is author or coauthor of about 200 scientific publications. Most of them are original research articles published in critically peer-reviewed renowned medical journals. His research covers echocardiography,[6] cardiac CT,[7] heart failure,[8] cardiac calcification[9] and cardiac rehabilitation.[10] Tenenbaum was especially involved in the research of various aspects of metabolic syndrome,[11] insulin resistance,[12] obesity[13] and the diabetes/cardiovascular interrelationship including residual risk concept.[14]
Cardiovascular diabetology
[change | change source]As a result of the efforts of Dr. Tenenbaum and his colleagues from many countries, a strong correlation between cardiovascular disease and diabetes was established . A new branch of medicine, cardiovascular diabetology, was set up.[15] In 2002 Tenenbaum and Prof. Fisman founded an international scientific journal named Cardiovascular Diabetology (BioMed Central, Springer Sciences Media Group, London). It was dedicated to all aspects of the diabetes/cardiovascular interrelationship.[16] Cardiovascular Diabetology now is the world’s foremost journal specifically devoted to this issue. It has the highest Impact Factor among journals of similar field. Tenenbaum serves as Co-Editor-in-Chief of Cardiovascular Diabetology.
Academic appointments
[change | change source]In 2006, he was nominated Professor of Cardiology at Sackler Faculty of Medicine, Tel Aviv University.
Besides his accomplishments as an investigator, Dr. Tenenbaum has had a distinguished contribution as a medical educator both for Israeli and foreign students and cardiologists. He has organized the program for Continuous Medical Education of cardiologists from the former Soviet Union.
Activity in professional societies and awards
[change | change source]Tenenbaum worked for the advancement of the Israel Heart Society and international organizations of cardiologists. He was Governor of The International Society of Cardiovascular Pharmacotherapy,[17] Co-founder and Chairman of the Israeli Heart Society Working Group on Cardiovascular Pharmacology and Drug Therapy[18] and Co-founder and Secretary General of the Cardiovascular Diabetology Research Foundation.
Tenenbaum received many international and Israeli scientific awards. They include the Jan J. Kellermann Award and the Henry Neufeld Prize.
References
[change | change source]- ↑ "FACULTY OF MEDICINE". Retrieved 6 December 2014.
- ↑ "Syndrome of high-altitude hypertrophic cardiomyopathy". NCBI. Retrieved 6 December 2014.
- ↑ "Noninvasive assessment of the function of the lesser circulation and of the right heart in mitral stenosis". NCBI. Retrieved 6 December 2014.
- ↑ "New approaches to noninvasive assessment of pulmonary artery pressure". NCBI. Retrieved 6 December 2014.
- ↑ "Prof Alexander Tenenbaum". Cardiab. Retrieved 6 December 2014.
- ↑ "Improved posterobasal segment function after thrombolysis is associated with decreased incidence of significant mitral regurgitation in a first inferior myocardial infarction". NCBI. Retrieved 6 December 2014.
- ↑ "Dual-helical CT for detecting aortic atheromas as a source of stroke: comparison with transesophageal echocardiography". NCBI. Retrieved 6 December 2014.
- ↑ "Functional class in patients with heart failure is associated with the development of diabetes". NCBI. Retrieved 6 December 2014.
- ↑ "Gender paradox in cardiac calcium deposits in middle-aged and elderly patients: mitral annular and coronary calcifications interrelationship". NCBI. Retrieved 6 December 2014.
- ↑ "Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortality". NCBI. Retrieved 6 December 2014.
- ↑ "Macrovascular complications of metabolic syndrome: an early intervention is imperative". NCBI. Retrieved 6 December 2014.
- ↑ "Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate". NCBI. Retrieved 6 December 2014.
- ↑ "Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients". NCBI. Retrieved 6 December 2014.
- ↑ "Hypertension in diet versus pharmacologically treated diabetics: mortality over a 5-year follow-up". NCBI. Retrieved 6 December 2014.
- ↑ "Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory Facets". Karger. Retrieved 6 December 2014.
- ↑ "Editors in Chief". Cardiab. Retrieved 6 December 2014.
- ↑ "Prof Alexander Tenenbaum". BioMed Central. Retrieved 6 December 2014.[permanent dead link]
- ↑ "Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis" (PDF). The Cardiovascular Drug Therapy. Retrieved 6 December 2014.